· Understand the druggable targets in the PSP pathogenetic process.
· Become familiar with active neuroprotection trials for PSP.
· Learn about available symptomatic management of PSP.
Session date:
06/06/2025 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Lawrence I. Golbe, MD

Facebook
X
LinkedIn
Forward